Nat Genet. 1994 Jun;7(2):180-4.

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al.

Source

Division of Neurology, Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, North Carolina 27710.

Abstract

Gene dosage of the apolipoprotein E (APOE) epsilon 4 allele is a major risk factor for familial Alzheimer disease (AD) of late onset (after age 60). Here we studied a large series of 115 AD case subjects and 243 controls as well as 150 affected and 197 unaffected members of 66 AD families. Our data demonstrate a protective effect of the epsilon 2 allele, in addition to the dose effect of the epsilon 4 allele in sporadic AD. Although a substantial proportion (65%) of AD is attributable to the presence of epsilon 4 alleles, risk of AD is lowest in subjects with the epsilon 2/epsilon 3 genotype, with an additional 23% of AD attributable to the absence of an epsilon 2 allele. The opposite actions of the epsilon 2 and epsilon 4 alleles further support the direct involvement of APOE in the pathogenesis of AD.

PMID:: 7920638; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Alzheimer's Disease - MedlinePlus Health Information

Supplemental Content

Related citations

[Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease]. [Seishin Shinkeigaku Zasshi. 1997]
[Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].
Shimada K, Yasuda M, Maeda K. Seishin Shinkeigaku Zasshi. 1997; 99(8):575-87.
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. [Neurology. 1993]
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ. Neurology. 1993 Aug; 43(8):1467-72.
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. [Science. 1993]
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Science. 1993 Aug 13; 261(5123):921-3.
Review [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism]. [Recenti Prog Med. 2002]
Review [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F, Solfrizzi V, D'Introno A, Capurso C, Colacicco AM, Torres F, Altomare E, Capurso A. Recenti Prog Med. 2002 Sep; 93(9):489-97.
Review Genetic dissection of Alzheimer disease, a heterogeneous disorder. [Proc Natl Acad Sci U S A. 1995]
Review Genetic dissection of Alzheimer disease, a heterogeneous disorder.
Schellenberg GD. Proc Natl Acad Sci U S A. 1995 Sep 12; 92(19):8552-9.

See reviews... See all...

Cited by 91 PubMed Central articles

Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways. [Int J Alzheimers Dis. 2011]
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways.
Olgiati P, Politis AM, Papadimitriou GN, De Ronchi D, Serretti A. Int J Alzheimers Dis. 2011; 2011:832379. Epub 2011 Dec 10.
Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients. [Dement Geriatr Cogn Dis Extra. 2011]
Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients.
Zamani M, Mehri M, Kollaee A, Yenki P, Ghaffarpor M, Harirchian MH, Shahbazi M. Dement Geriatr Cogn Dis Extra. 2011 Jan; 1(1):180-9. Epub 2011 Jun 29.
Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk. [Mol Neurodegener. 2011]
Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk.
Simmons CR, Zou F, Younkin SG, Estus S. Mol Neurodegener. 2011 Aug 25; 6:62. Epub 2011 Aug 25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Gene (OMIM)
Gene records associated with Online Mendelian Inheritance in Man (OMIM) records that cite the current articles in their reference lists.
Nucleotide (Weighted)
Nucleotide records associated with the current articles through the Gene database. These are the related sequences on the Gene record that are added manually by NCBI.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
OMIM (cited)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as reference cited at the end of the OMIM record.
Protein (Weighted)
Protein records associated with the current articles through related Gene database records. These are the related sequences on the Gene record that are added manually by NCBI.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer dis...
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.
Nat Genet. 1994 Jun ;7(2):180-4.

PubMed
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease ...
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Science. 1993 Aug 13 ;261(5123):921-3.

PubMed
The stem cell population of Arabidopsis shoot meristems in maintained by a regul...
The stem cell population of Arabidopsis shoot meristems in maintained by a regulatory loop between the CLAVATA and WUSCHEL genes.
Cell. 2000 Mar 17 ;100(6):635-44.

PubMed
Determination of cobalamin in nutritive supplements and chlorella foods by capil...
Determination of cobalamin in nutritive supplements and chlorella foods by capillary electrophoresis-inductively coupled plasma mass spectrometry.
J Agric Food Chem. 2008 Feb 27 ;56(4):1210-5. Epub 2008 Feb 2 .

PubMed
Plants need their vitamins too.
Plants need their vitamins too.
Curr Opin Plant Biol. 2007 Jun ;10(3):266-75. Epub 2007 Apr 16 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Cited by 91 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information